The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability
Abstract
Regulation of endothelial permeability is poorly understood. Previous studies have shown that endothelial cells contain phosphodiesterase (PDE) isoenzymes II-IV and that simultaneous adenylate cyclase activation and/or PDE inhibition blocked endothelial hyperpermeability (J.Clin.Invest. 91: 1421-1428, 1993). We now focused on a possible role for guanosine 3',5'-cyclic monophosphate (cGMP)-dependent mechanisms and studied H2O2-exposed porcine pulmonary artery endothelial cell monolayers. Pretreatment of cells with different nitric oxide (NO) donors or atrial natriuretic peptide (ANP) increased endothelial cGMP-content severalfold and blocked H2O2-related effects on permeability; opposite results were obtained with a NO synthase inhibitor. Determination of cGMP degradation in nitroprusside-exposed endothelial cells identified PDE II as the major cGMP metabolizing pathway, whereas PDE III and IV contributed little or nothing. Inhibition of PDE II reduced H2O2-related endothelial hyperpermeability, an effect that could be enhanced synergistically by simultaneous guanylate cyclase activation. In summary, these studies indicate that cGMP-dependent mechanisms (NO donors, ANP, and dibutyryl-cGMP) blocked H2O2-related increases in endothelial permeability. The major cGMP degrading pathway in endothelial cells was PDE II, thereby substituting the missing PDE V in these cells. Simultaneous guanylate cyclase activation and/or PDE II inhibition may be a valuable approach to treat endothelial hyperpermeability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Enterochromaffin cells secrete serotonin and signaling peptides (for example, corticotropin-releasing hormone, cholecystokinin and somatostatin) in response to various physiological and pathological luminal stimuli,53-55 such as microbial factors or bacterial toxins,56-58 as well as central stimuli (see discussion above).31,32”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [56]
Citations
Cites
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Intracellular cyclic GMP receptor proteins
Lincoln, T., & Cornwell, T. L. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.2.7680013 · Cited by 651
Atrial natriuretic peptide: synthesis, release, and metabolism.
Ruskoaho, H. J. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00456-9 · Cited by 547
Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
Torphy, T. J., & Undem, B. J. (1991) · Thorax · doi:10.1136/thx.46.7.512 · Cited by 380
Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage.
Kurose, I., Kubes, P., Wolf, R., Anderson, D. C., Paulson, J. C., Miyasaka, M., & Granger, D. N. (1993) · Circulation Research · doi:10.1161/01.res.73.1.164 · Cited by 342
Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system
Walter, U. (2005) · Springer eBooks · doi:10.1007/bfb0032675 · Cited by 219
Schnittler, H., Wilke, A., Gress, T. M., Suttorp, N., & Drenckhahn, D. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018335 · Cited by 197
Self-citationRole of phosphodiesterases in the regulation of endothelial permeability in vitro.
Suttorp, N., Weber, U., Welsch, T., & Schudt, C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116346 · Cited by 186
Self-citationBhakdi, S., Greulich, S., Muhly, M., Eberspächer, B., Becker, H., Thiele, A., & Hugo, F. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.737 · Cited by 134
Lugnier, C., & Schini‐Kerth, V. B. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90650-a · Cited by 127
Cited by
Sorted by citations
Principles and clinical implications of the brain-gut-enteric microbiota axis
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342
Lugnier, C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 893
Michel, C. C., & CURRY, F. E. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.3.703 · Cited by 812
Overview of PDEs and Their Regulation
Omori, K., & Kotera, J. (2007) · Circulation Research · doi:10.1161/01.res.0000256354.95791.f1 · Cited by 797
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
Torphy, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 655
Metadata
- Authors
- Suttorp, N., Hippenstiel, S., Fuhrmann, M., Krull, M., & Podzuweit, T.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Department of Internal Medicine, Justus Liebig-University of Giessen,Germany.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 1996-03-01
- Volume
- 270
- Issue
- 3
- Pages
- C778-C785
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2413676558
- Cited by
- 133
- References
- 20
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 1 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Cell Physiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- endothelial hyperpermeability, nitric oxide, cyclic GMP, hydrogen peroxide, atrial natriuretic peptide, guanylate cyclase, endothelial permeability, pulmonary artery endothelial cells, nitric oxide synthase, cGMP degradation
- MeSH terms
- Animals, Arginine, Cell Membrane Permeability, Cells, Cultured, Electric Conductivity, Endothelium, Vascular, Enzyme Inhibitors, Escherichia coli, Nitroglycerin, Hemolysin Proteins, Hydrogen Peroxide, Isoenzymes, Kinetics, Molsidomine, Nitric Oxide, Nitroprusside, Phosphoric Diester Hydrolases, Pulmonary Artery, Swine, Nitric Oxide Synthase, Nitroarginine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
